SightfileU.S. market data from official filings

Companies › CABA

CABALETTA BIO INC (CABA)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001759138 · EDGAR filings · Updated 2026-07-27

CABALETTA BIO INC (CABA) has reported institutional ownership of 76.1%, with 108 institutional managers holding positions valued at $227.5M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
76.1%
Institutional managers
108
Reported 13F value
$227.5M
Insider activity
8 trans.
$296.2K net buying
Data flags
1 active
from SEC filings

Filings this week (2)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, CABALETTA BIO INC has 108 institutional holders and institutional ownership of 76.1%.

Insider activity

Insiders reported 8 transactions (8 buys, 0 sells) across 8 reporting insiders, with a net reported value of $296.2K.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-14 (recurring since 2025-03-31) — source filing. The authoritative details are those stated in the filing itself.

Related companies

Minerva Neurosciences Inc (NERV) · OPKO HEALTH INC (OPK) · VIEMED HEALTHCARE INC (VMD) · SINOVAC BIOTECH LTD (SVA) · C4 THERAPEUTICS INC (CCCC) · CLIMB BIO INC (CLYM)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-27.